Navigating the DEA’s Cannabis Rescheduling Shift

As the DEA moves toward rescheduling cannabis, the industry is bracing for a complex transformation defined by regulatory uncertainty and potential legal headwinds. While federal agencies have taken an unexpectedly active role in supporting this transition, the timeline for full implementation remains long and subject to likely legal challenges. Blunt Business speaks with Chris Lynch, partner at Dickinson Wright to chime in.

For businesses, the landscape is currently defined by heavy operational burdens, such as state-specific excise taxes and residency requirements; however, upcoming shifts like Section 280E relief and the prospect of federal trademark protection signal a...